Potential role of PCSK9 inhibitors

3' education - Nov. 26, 2014 - VBWG Chicago - Michael J Koren

Dr Michael J Koren MD, Jacksonville, FL, USA, shares his rationale for targeting PCSK9, based on epidemiology and recent clinical developments and discusses implications for future lipid management